Michael Goldstein, MD
Transplant Surgery Physician in Hackensack, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,025 in Transplant Surgery Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Michael Goldstein, MD reported a CMS MIPS final score of 75.8/100 - below the 83.1 national average - and filed 1,952 Medicare Part D claims in 2023.
- 75.8/100
- MIPS score · -7 vs avg
- 2K
- Part D claims, 2023
- 84%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Michael Goldstein, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
76 15th percentile higher than 15% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Michael Goldstein, MD sits
This provider among transplant surgery physician peers
Across the 248 transplant surgery physician providers who report both Medicare Part D prescribing and a MIPS quality score, Michael Goldstein, MD writes more Part D claims than 96% of them and scores higher on MIPS quality than 13% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one transplant surgery physician peer from a representative sample of 60; the gold marker is Michael Goldstein, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Michael Goldstein, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Michael Goldstein, MD?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New Jersey
How Transplant Surgery Physician compares to other specialties among New Jersey providers
Transplant Surgery Physician ranks #320 among New Jersey's specialties (0% of in-state providers)
Each bar is a specialty's share of the New Jersey provider total, by primary NUCC taxonomy. The highlighted bar is Transplant Surgery Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Michael Goldstein, MD's 2023 MIPS final score plotted against the Transplant Surgery Physician national average
- MIPS Final Score
- 75.8/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Transplant Surgery Physician) - 75.8/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Transplant Surgery Physician US NPIs
75.8/100 MIPS final score - 7.3 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Transplant Surgery Physician. Quality dim: 68.7. Cost dim: 50.7.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Michael Goldstein, MD appears in the CMS NPPES registry as a Transplant Surgery Physician provider holding MD credentials at 20 PROSPECT AVE, Hackensack, NJ, 07601, with a listed phone of (551) 996-2608. NPI 1962426601 was issued on 07/26/2006.
Medicare Part D records for calendar year 2023 show 1,952 prescription claims written by this provider, covering 194 Medicare beneficiaries and totaling roughly $214K in drug spend, split 9% brand-name and 84% generic by claim count, with an opioid prescribing rate of 3.7%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75.8/100 for the 2023 performance year (Quality 68.7, Cost 50.7), compared with the national average of 83.1.
Transplant Surgery Physician is a narrow specialty nationwide, with 1,025 enrolled providers across 48 states and an average of 275 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1962426601 |
|---|---|
| Specialty | Transplant Surgery Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 07/26/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Michael Goldstein, MD's current license status, disciplinary history, and board certifications with the New Jersey State Board of Medical Examiners in New Jersey before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1962426601 is the unique 10-digit identifier CMS uses to link Goldstein across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Michael Goldstein, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Michael Goldstein, MD. Source: openpaymentsdata.cms.gov.
Total received
$22.3K
Largest payer
SANOFI-AVENTIS U.S. LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Generic-heavy
9% brand-name claims vs 84% generic, on 1,952 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,347
- Total Day Supply
- 67,362
- Brand vs Generic
- 9% brand / 84% generic
- Brand Drug Cost
- $143K
- Generic Drug Cost
- $64K
- Opioid Claims
- 72 (3.7% rate)
- Antibiotic Claims
- 302
Patient Demographics
- Average Patient Age
- 62.3 years
- Avg HCC Risk Score
- 6.46
- Gender Split
- 22% female / 78% male
- Age Distribution
- <65: 84, 65-74: 73, 75-84: N/A, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Michael Goldstein, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Sulfamethoxazole-T…
Sulfamethoxazole-Trimethoprim
280 claims
- Nifedipine Er
Nifedipine Er
187 claims
- Valganciclovir Hcl
Valganciclovir Hcl
143 claims
- Pantoprazole Sodium
Pantoprazole Sodium
117 claims
- Tamsulosin Hcl 97
Tamsulosin Hcl
97 claims
- Furosemide 74
Furosemide
74 claims
- Prednisone 68
Prednisone
68 claims
- Nystatin 65
Nystatin
65 claims
| Drug | Claims |
|---|---|
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 280 |
| Nifedipine Er Nifedipine | 187 |
| Valganciclovir Hcl | 143 |
| Pantoprazole Sodium | 117 |
| Tamsulosin Hcl | 97 |
| Furosemide | 74 |
| Prednisone | 68 |
| Nystatin | 65 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 63 |
| Atorvastatin Calcium | 60 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Transplant Surgery Physician Overview
How Michael Goldstein, MD fits within the Transplant Surgery Physician landscape nationally.
Michael Goldstein, MD's 1,952 claims are above the specialty average of 275.
Nearby Transplant Surgery Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Goldstein.
Compare Transplant Surgery Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New Jersey medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Transplant Surgery Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New Jersey
Frequently Asked Questions
What is Michael Goldstein, MD's specialty? ▼
How much does Michael Goldstein, MD prescribe under Medicare Part D? ▼
What is Michael Goldstein, MD's Medicare quality score? ▼
Where is Michael Goldstein, MD located? ▼
What is Michael Goldstein, MD's NPI number? ▼
Does Michael Goldstein, MD prescribe more brand-name or generic drugs? ▼
Does Michael Goldstein, MD prescribe opioids? ▼
How many Transplant Surgery Physician providers are there in the US? ▼
What drugs does Michael Goldstein, MD prescribe most often? ▼
Does Michael Goldstein, MD accept Medicare? ▼
How can I verify Michael Goldstein, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor Editorial
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.